Steven R. Beauchamp - Feb 3, 2023 Form 4/A - Amendment Insider Report for Paylocity Holding Corp (PCTY)

Role
Co-Chief Executive Officer, Director
Signature
/s/ Kris Kang, attorney-in-fact to Steven R. Beauchamp
Stock symbol
PCTY
Transactions as of
Feb 3, 2023
Transactions value $
-$425,100
Form type
4/A - Amendment
Date filed
2/15/2023, 03:22 PM
Date Of Original Report
Feb 7, 2023
Previous filing
Nov 17, 2022
Next filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCTY Common Stock, par value $0.001 Options Exercise $33.2K +1.95K +0.11% $17.00 1.76M Feb 3, 2023 Direct F1, F2
transaction PCTY Common Stock, par value $0.001 Tax liability -$163K -695 -0.04% $235.00 1.76M Feb 3, 2023 Direct F1
transaction PCTY Common Stock, par value $0.001 Sale -$295K -1.26K -0.07% $235.00 1.76M Feb 3, 2023 Direct F2
holding PCTY Common Stock, par value $0.001 220K Feb 3, 2023 by IRIE Family Trust
holding PCTY Common Stock, par value $0.001 22.5K Feb 3, 2023 by IRIE Foundation

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCTY Non-Qualified Stock Option (right to buy) Options Exercise $0 +1.95K +15.27% $0.00 14.7K Feb 3, 2023 Common Stock, par value $0.001 1.95K $17.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correct the shares reported in the Form 4 filed on February 7, 2023 with respect to the amount of non-qualified stock options exercised, to correct the amount of shares withheld for the reporting person's tax and exercise price obligations upon the exercise of non-qualified stock options and to correct the total amount of derivative securities beneficially owned following the reported transaction.
F2 The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on November 17, 2022.